Royalty Report: Cannabis, Drugs, Tobacco – Collection: 29905


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 8


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8

Primary Industries

  • Cannabis
  • Drugs
  • Tobacco
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 29905

License Grant
The Licensor and Licensee amended their Agreement and expanded the scope of their partnership.The amended Agreement calls for the Licensor to serve as the developer of a new facility to be called the Illinois Medical Cannabis Center. The Licensee plans to use the IMCC to cultivate,process and distribute medical cannabis to many of the state's 52 newly Licensed medical dispensaries.  
Licensor will receive royalties and consulting fees.
License Property
When fully constructed,the IMCC will contain approximately 285,000 square feet capable of producing an estimated 50,000 pounds annually of medical cannabis owned by the Licensor. Licensor will provide working capital funding and horticultural assistance to the Licensor.
Field of Use
Medical cannabis distribution.

IPSCIO Record ID: 365304

License Grant
Various Licensees operate a state-of-the-art cannabis cultivation, processing and manufacturing facility from the Licensor.
License Property
The facility is used for development, traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development.
Field of Use
Field of use is for medical cannabis and the newly emerging adult-use cannabis marketplace.

IPSCIO Record ID: 275601

License Grant
Through various third party processors, the Canadian Company, will provide medical cannabis products under the Sollievo label. The Company’s processing partner uses an exclusive, proprietary, and patentable formula in its medical products, paying the Company a product royalty on the wholesale of the products sold to dispensaries or delivery services. The Company seeks to expand the brand state by state through processor relationships, thereby creating a national line of data driven medical cannabis products tailored to patient’s needs.
License Property
The Company operates a growing network of physician- staffed medical cannabis clinics with a primary focus on enabling patients to improve and protect their health.
Field of Use
This agreement pertains to the cannabis industry.

IPSCIO Record ID: 239294

License Grant
In this agreement the Licensee is to produce cannabis-infused baked goods and other edibles in Licensor’s production facility upon approval of Licensor’s Nevada Medical Marijuana Production License.
License Property
The Company (Licensor) seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical-grade cannabis, cannabis concentrates and cannabinoid therapies.
Field of Use
This agreement pertains to the drug industry relating to cannabis-based therapeutic products.

IPSCIO Record ID: 377948

License Grant
As part of this partnership, Canadian Party A will be provided with exclusive access to Australian Party B’s GMP manufacturing capabilities at the Southport Facility located in Queensland, Australia.  The partnership also marks the first GMP manufactured products to be sold through Party A in Australia, and provides Party A with the capability to deliver GMP-grade products to Latin America, Europe, UK and Asia-Pacific.
License Property
Good Manufacturing Practices (GMP) manufacturing products consists of cannabis products and cannabis cultivation solutions.
Field of Use
Field of use is for manufacturing and distributing cannabis.

IPSCIO Record ID: 30002

License Grant
The Licensor and the Licensee wish to amend the License Agreement and terms to include terms, investments, assets, revenue sharing, and ownership interest of the parties for their mutual benefit under this Agreement;

The Licensor shall have the sole ownership, rights and interest in all assets, property and facilities, or products for all mutual business, new business ventures, and opportunities under the License Agreement.

The Licensee shall pay Licensing Fees & Royalties to the Licensor, after deducting and paying all operating costs, taxes, administration, professional and other fees, or other costs of business, received under the License Agreement for the marketing, manufacturing, production, sale or distribution of the Products.

License Property
Assets include but not limited to

Land, Grows and harvested crops, CA production, Extract machinery and business operations, Once Co2 Extract machine, Buildings, Tools and equipment, Inventories Cannabis or hemp, Extracts, Packaged Goods,

Plant and plant by-products 16 strains.

Field of Use
Future endeavors Non-profit medical marijuana collectives (dispensaries),

Collective to be developed (location to be later define) and run under the Cannabis Science Brand or as specified by Cannabis Science, Other for-profit business opportunities, Treatment Centers, Drug Development Programs, Media, Retail Seed Business, Laboratories and equipment.

IPSCIO Record ID: 250292

License Grant
The Canadian Licensor licensed, for a five-year period, its Canadian portfolio of cannabis products to the Canadian Licensee.
License Property
The Licensor is a North American cannabis products and brands company.
Field of Use
The Licensee is a Canadian medical cannabis company.

IPSCIO Record ID: 266631

License Grant
Licensor hereby grants to Licensee an exclusive, world-wide, License to use the HDI Technology solely in the Cannabis Application, for the purpose of processing Cannabis Materials using the SPR in the Cannabis Industry. (The aforesaid license grant is herein sometimes referred to as the “License”).

Licensor grants an exclusive license to all Licensors Intellectual Property and patented technology and creates a partnership to bring their patented controlled cavitation process to the cannabis industry.

License Property
Licensor has the Shockwave Powerâ„¢ Reactor (SPR) rights for mixing and Heating, Hydrogenating Substances, Continuous Hydrodynamics cavitation crystallization, and four other patents.

Licensor is the owner of certain Technology called ShockWave Power™. Licensor owns Intellectual Property (“IP”, defined below), manifested in Patents, Trade Secrets, and Know How, which are embodied in Licensor's proprietary ShockWave Power Reactor/Extractor (“SPR™), and which IP is useful in a variety of industries including but not limited to those industries that extract, mix, heat, hydrate, homogenize and crystallize materials.

“Cannabis Industry” means the industry where cannabis oils and other compounds containing cannabis (“Cannabis Materials”, defined below) are derived from the cannabis sativa, cannabis indica, and cannabis ruderalis plants, including marijuana and hemp, either singularly or by mixing with substances other than cannabis oils.

“Cannabis Application” means the use of the Licensor Technology to achieve a specific result when processing only “Cannabis Materials”.

“ShockWave Power Reactor/Xtractor (SPR™”) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.

“ShockWave Power Reactor/Xtractor (SPR™”) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.

“Standalone SPR” means an SPR mounted on a skid containing no other equipment other than that necessary to run the SPR.

Field of Use
Illustrative, but not all, areas of use of the Licensed Technology covered by this Agreement are
(i) UV light for decarboxylation of THC
(ii) Crystallization of CBD or THC
(iii) mixing of cannabis oil with other substances to create foods, beverages, or other products which are themselves not cannabis oils
(iv) Use of Electrochemistry or UltraViolate (UV) SPR’s or other advanced oxidation materials to produce radicals for the production of CBN
(v) Hydrogenation of cannabis oils
(vi) processing of hemp oils for biofuels.
(vii) Development of an SPR for supercritical CO2
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.